Nordion Incorporated (NDN) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Nordion Incorporated Company Snapshot

Business Description:

Nordion Incorporated operates in the Analytical instruments sector. Nordion Inc. (Nordion), formerly MDS Inc. is a global life sciences company that provides products and services for the prevention, diagnosis and treatment of disease. The Company operates in three segments: Medical Isotopes, Targeted Therapies and Sterilization Technologies. Its segments are engaged in the development, manufacturing and distribution of radioactive isotopes to produce products for the prevention, diagnosis and treatment of disease. During the fiscal year ended October 31, 2010 (fiscal 2010), Nordion completed the sale of Analytical Technologies (US) Inc., Pharma Services (US) Inc., Pharma Services GB Limited, Pharma Services Central Lab, S.A.S. and Applied Biosystems/Analytical Technologies Instruments partnership. On March 5, 2010, the Company completed the sale of Early Stage to Ricerca Biosciences, LLC and Celerion, Inc. On January 29, 2010, it completed the sale of MDS Analytical Technologies to Danaher Corporation. In our complete report available for purchase the company is compared to: Cepheid, Harvard Bioscience, Inc. and Iris International Inc..

Nordion Incorporated

Stock Performance Chart for Nordion Incorporated

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 10.00
(Figures in Canadian Dollars)

1 Week	0.0%		13 Weeks	10.6%

4 Weeks	7.5%		52 Weeks	-12.9%

Nordion Incorporated Key Data:

	Ticker:	NDN	Country:	CANADA

	Exchanges:	NYSE TOR OTH	Major Industry:	Miscellaneous

			Sub Industry:	Medical Services

	2011 Sales	269,842,608 (Year Ending Jan 2012).	Employees:	546

	Currency:	Canadian Dollars	Market Cap:	623,785,210

	Fiscal Yr Ends:	October	Shares Outstanding:	62,378,521

	Share Type:	Common	Closely Held Shares:	114,769

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.